1.7(top 50%)
impact factor
616(top 50%)
papers
6.0K(top 20%)
citations
29(top 20%)
h-index
1.9(top 50%)
impact factor
1.2K
all documents
6.1K
doc citations
44(top 20%)
g-index

Top Articles

#TitleJournalYearCitations
1Stress and eating behaviorsMinerva Endocrinologica2013227
2Glucocorticoids, stress, and fertilityMinerva Endocrinologica2010165
3Neuropsychiatric aspects of hypothyroidism and treatment reversibility.Minerva Endocrinologica200789
4Anaplastic thyroid cancer: prevalence, diagnosis and treatmentMinerva Endocrinologica200875
5Diabetes and the hypothalamo-pituitary-adrenal (HPA) axisMinerva Endocrinologica200369
6Neuroprotection of sex steroidsMinerva Endocrinologica201068
7Thyroid hormone and the cardiovascular systemMinerva Endocrinologica200458
8The association between papillary carcinoma and chronic lymphocytic thyroiditis: does it modify the prognosis of cancer?Minerva Endocrinologica200849
9Andrological characterization of the patient with diabetes mellitusMinerva Endocrinologica200948
10The role of PTEN in the progression and survival of prostate cancerMinerva Endocrinologica200346
11Diagnosis and treatment of pituitary adenomasMinerva Endocrinologica200438
12Obesity and polycystic ovary syndromeMinerva Endocrinologica201537
13Regulation of insulin-like growth factor-I in skeletal muscle and muscle cellsMinerva Endocrinologica200336
14Aromatase and prostate cancerMinerva Endocrinologica200636
15Is late-onset hypogonadotropic hypogonadism a specific age-dependent disease, or merely an epiphenomenon caused by accumulating disease-burden?Minerva Endocrinologica201636
16Management of the metabolic syndromeMinerva Endocrinologica200435
17Protective and regenerative effects of the GH/IGF-I axis on the brainMinerva Endocrinologica200735
18Adipocytokines and aging: adiponectin and leptinMinerva Endocrinologica201335
19Thyroid cancer yield in patients with Graves' diseaseMinerva Endocrinologica200334
20Lower irisin levels in coronary artery disease: a meta-analysisMinerva Endocrinologica202033
21Growth hormone binding protein. The soluble growth hormone receptorMinerva Endocrinologica200233
22Diagnosis, treatment, prognostic factors and long-term outcome in papillary thyroid carcinomaMinerva Endocrinologica200833
23Effects of physical exercise on the female reproductive systemMinerva Endocrinologica201333
24Optimizing therapy for radioactive iodine-refractory differentiated thyroid cancer: current state of the art and future directionsMinerva Endocrinologica201232
25Pioglitazone reduces blood pressure in non-dipping diabetic patientsMinerva Endocrinologica200432
26Role of endocrine and inflammatory alterations in comorbid somatic diseases of post-traumatic stress disorderMinerva Endocrinologica200632
27COVID-19: the endocrine opportunity in a pandemicMinerva Endocrinologica202031
28Diabetes mellitus and the risk of cancerMinerva Endocrinologica201131
29Glucocorticoids and 11beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndromeMinerva Endocrinologica200730
30Von Recklinghausen's neurofibromatosis associated with duodenal somatostatinoma. A case report and review of the literatureMinerva Endocrinologica200429
31Update--steroidogenic factor 1 (SF-1, NR5A1)Minerva Endocrinologica201029
32Cardiovascular morbidity and mortality in thyroid dysfunctionMinerva Endocrinologica200528
33Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-upMinerva Endocrinologica201328
34Thyroid gland diseases in adult patients with diabetes mellitusMinerva Endocrinologica200527
35Thyroid cancer in infants and adolescents after ChernobylMinerva Endocrinologica200827
36Vitamin D and psoriasis: an update for dermatologists and nutritionistsMinerva Endocrinologica202026
37Structure and regulation of the growth hormone secretagogue receptorMinerva Endocrinologica200226
38Obesity and the metabolic syndromeMinerva Endocrinologica200426
39Thyroid disease in pregnancy and childhoodMinerva Endocrinologica200526
40Role of serotonin in gastrointestinal physiology and pathologyMinerva Endocrinologica201126
41The role of insulin-like growth factor system in the adrenocortical tumorsMinerva Endocrinologica201825
42Effects of thyroid status on bone metabolism: a primary role for thyroid stimulating hormone or thyroid hormone?Minerva Endocrinologica200525
43Anomalies in the inflammatory response in endometriosis and possible consequences: a reviewMinerva Endocrinologica201225
44Long-term effectiveness and safety of liraglutide in clinical practiceMinerva Endocrinologica201325
45Associations between vitamin D levels and polycystic ovary syndrome phenotypesMinerva Endocrinologica201924
46New-generation anti-obesity drugs: naltrexone/bupropion and liraglutide. An update for endocrinologists and nutritionistsMinerva Endocrinologica202024
47Hormone replacement therapy in postmenopausal womenMinerva Endocrinologica200524
48Obesity and the polycystic ovary syndromeMinerva Endocrinologica200724
49Energy expenditure: a critical determinant of energy balance with key hypothalamic controlsMinerva Endocrinologica200724
50Molecular determinants of the response to medical treatment of growth hormone secreting pituitary neuroendocrine tumorsMinerva Endocrinologica201923